Amy C. Keller

980 total citations
32 papers, 664 citations indexed

About

Amy C. Keller is a scholar working on Physiology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Amy C. Keller has authored 32 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Physiology, 7 papers in Molecular Biology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Amy C. Keller's work include Adipose Tissue and Metabolism (10 papers), Nitric Oxide and Endothelin Effects (7 papers) and Natural Antidiabetic Agents Studies (5 papers). Amy C. Keller is often cited by papers focused on Adipose Tissue and Metabolism (10 papers), Nitric Oxide and Endothelin Effects (7 papers) and Natural Antidiabetic Agents Studies (5 papers). Amy C. Keller collaborates with scholars based in United States, Germany and Austria. Amy C. Keller's co-authors include Edward J. Kennelly, Jane E.B. Reusch, Leslie A. Knaub, Jun Ma, Kan He, Adam Kavalier, Matthew W. Miller, Corey D. Broeckling, Elizabeth P. Ryan and Tiffany L. Weir and has published in prestigious journals such as The Journal of Physiology, Diabetes and Journal of Applied Physiology.

In The Last Decade

Amy C. Keller

31 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy C. Keller United States 14 219 208 151 83 73 32 664
Ivan Rubio‐Gayosso Mexico 15 174 0.8× 173 0.8× 144 1.0× 93 1.1× 80 1.1× 36 783
Sattar Gorgani‐Firuzjaee Iran 16 345 1.6× 163 0.8× 224 1.5× 43 0.5× 68 0.9× 39 965
Lawrence A. Olatunji Nigeria 17 185 0.8× 330 1.6× 137 0.9× 68 0.8× 82 1.1× 105 940
Eulises Díaz‐Díaz Mexico 17 214 1.0× 154 0.7× 198 1.3× 40 0.5× 66 0.9× 41 734
Arzu Seven Türkiye 19 278 1.3× 248 1.2× 166 1.1× 45 0.5× 49 0.7× 37 1.0k
İrfan Değirmenci Türkiye 17 218 1.0× 125 0.6× 85 0.6× 44 0.5× 104 1.4× 58 776
Margarita Díaz-Flores Mexico 18 248 1.1× 139 0.7× 131 0.9× 77 0.9× 36 0.5× 37 754
Junping Wei China 13 269 1.2× 173 0.8× 97 0.6× 25 0.3× 63 0.9× 29 689
Uday Kumar Putcha India 17 236 1.1× 140 0.7× 147 1.0× 32 0.4× 65 0.9× 38 831
Marcella L. Porto Brazil 18 282 1.3× 157 0.8× 188 1.2× 30 0.4× 118 1.6× 37 920

Countries citing papers authored by Amy C. Keller

Since Specialization
Citations

This map shows the geographic impact of Amy C. Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy C. Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy C. Keller more than expected).

Fields of papers citing papers by Amy C. Keller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy C. Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy C. Keller. The network helps show where Amy C. Keller may publish in the future.

Co-authorship network of co-authors of Amy C. Keller

This figure shows the co-authorship network connecting the top 25 collaborators of Amy C. Keller. A scholar is included among the top collaborators of Amy C. Keller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy C. Keller. Amy C. Keller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keller, Amy C. & Miguel A. Lanaspa. (2025). Catechins for use in cardiovascular disease: Molecular mechanisms and contemporary bioassays. Journal of Pharmaceutical and Biomedical Analysis. 268. 117216–117216. 1 indexed citations
2.
Knaub, Leslie A., Gregory B. Pott, Kendall S. Hunter, et al.. (2025). Thermoneutral-housed rats demonstrate impaired perivascular adipose tissue and vascular crosstalk. Journal of Hypertension. 43(5). 752–767. 1 indexed citations
3.
Nokoff, Natalie, Travis Nemkov, Melanie Cree‐Green, et al.. (2024). Differences in cardiorespiratory fitness by gonadotropin-releasing hormone agonist treatment before and after testosterone in transgender adolescents. Journal of Applied Physiology. 137(5). 1470–1483.
4.
Kefaloyianni, Eirini, Hao Dun, Amy C. Keller, et al.. (2022). Identification of kidney injury–released circulating osteopontin as causal agent of respiratory failure. Science Advances. 8(8). 53 indexed citations
5.
Vaughan, Owen R., Fredrick J. Rosario, Laura A. Cox, et al.. (2022). Maternal obesity causes fetal cardiac hypertrophy and alters adult offspring myocardial metabolism in mice. The Journal of Physiology. 600(13). 3169–3191. 24 indexed citations
6.
Keller, Amy C., et al.. (2021). A characterized saponin-rich fraction of Momordica charantia shows antidiabetic activity in C57BLK/6 mice fed a high fat diet. Phytomedicine Plus. 1(4). 100134–100134. 6 indexed citations
7.
Park, Youngmin, Amy C. Keller, Benjamin F. Miller, et al.. (2019). Acute estradiol treatment reduces skeletal muscle protein breakdown markers in early- but not late-postmenopausal women. Steroids. 146. 43–49. 23 indexed citations
8.
Keller, Amy C., et al.. (2018). Sepiapterin Improves Vascular Reactivity and Insulin‐Stimulated Glucose in Wistar Rats. Oxidative Medicine and Cellular Longevity. 2018(1). 7363485–7363485. 7 indexed citations
9.
Scalzo, Rebecca L., Leslie A. Knaub, Amy C. Keller, et al.. (2018). Glucagon-like peptide-1 receptor antagonism impairs basal exercise capacity and vascular adaptation to aerobic exercise training in rats. Physiological Reports. 6(13). e13754–e13754. 12 indexed citations
10.
Keller, Amy C., Leslie A. Knaub, Ron J. Bouchard, et al.. (2016). Differential Mitochondrial Adaptation in Primary Vascular Smooth Muscle Cells from a Diabetic Rat Model. Oxidative Medicine and Cellular Longevity. 2016(1). 8524267–8524267. 14 indexed citations
11.
Keller, Amy C., Hussain Badani, P. Mason McClatchey, et al.. (2016). Varicella zoster virus infection of human fetal lung cells alters mitochondrial morphology. Journal of NeuroVirology. 22(5). 674–682. 6 indexed citations
12.
Keller, Amy C., et al.. (2015). Fully automated software for quantitative measurements of mitochondrial morphology. Mitochondrion. 26. 58–71. 12 indexed citations
13.
Keller, Amy C., et al.. (2014). Saxagliptin Restores Vascular Mitochondrial Exercise Response in the Goto-Kakizaki Rat. Journal of Cardiovascular Pharmacology. 65(2). 137–147. 43 indexed citations
14.
Miller, Matthew W., Leslie A. Knaub, Amy C. Keller, et al.. (2013). Nitric oxide regulates vascular adaptive mitochondrial dynamics. American Journal of Physiology-Heart and Circulatory Physiology. 304(12). H1624–H1633. 55 indexed citations
15.
Keller, Amy C., Tiffany L. Weir, Corey D. Broeckling, & Elizabeth P. Ryan. (2013). Antibacterial activity and phytochemical profile of fermented Camellia sinensis (fuzhuan tea). Food Research International. 53(2). 945–949. 53 indexed citations
16.
Keller, Amy C., et al.. (2011). Saponins from the traditional medicinal plant Momordica charantia stimulate insulin secretion in vitro. Phytomedicine. 19(1). 32–37. 149 indexed citations
17.
Ma, Jun, Paul Whittaker, Amy C. Keller, et al.. (2010). Cucurbitane-Type Triterpenoids fromMomordica charantia. Planta Medica. 76(15). 1758–1761. 39 indexed citations
18.
Keller, Amy C., Ina Vandebroek, Youping Liu, et al.. (2008). Costus spicatus tea failed to improve diabetic progression in C57BLKS/J db/db mice, a model of type 2 diabetes mellitus. Journal of Ethnopharmacology. 121(2). 248–254. 21 indexed citations
19.
20.
Augustin, Albert J., Amy C. Keller, Frank Koch, Bernhard Jurklies, & H. Burkhard Dick. (2001). Einfluss des retinalen Koagulationsstatus auf oxidative Metabolite und VEGF bei 208 Patienten mit proliferativer diabetischer Retinopathie12. Klinische Monatsblätter für Augenheilkunde. 218(2). 89–94. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivan Rubio‐Gayosso Breakdown of academic impact, for papers by Sattar Gorgani‐Firuzjaee Breakdown of academic impact, for papers by Lawrence A. Olatunji Breakdown of academic impact, for papers by Eulises Díaz‐Díaz Breakdown of academic impact, for papers by Arzu Seven Breakdown of academic impact, for papers by İrfan Değirmenci Breakdown of academic impact, for papers by Margarita Díaz-Flores Breakdown of academic impact, for papers by Junping Wei Breakdown of academic impact, for papers by Uday Kumar Putcha Breakdown of academic impact, for papers by Marcella L. Porto
Rankless by CCL
2026